These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 640576)

  • 1. Oral testosterone, a reappraisal.
    Daggett PR; Wheeler MJ; Nabarro JD
    Horm Res; 1978; 9(3):121-9. PubMed ID: 640576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of primary hypogonadism in men by the transdermal administration of testosterone.
    Findlay JC; Place V; Snyder PJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):369-73. PubMed ID: 2493029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets.
    Zacharin MR; Warne GL
    Arch Dis Child; 1997 Jun; 76(6):495-9. PubMed ID: 9245845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men.
    Yaron M; Greenman Y; Rosenfeld JB; Izkhakov E; Limor R; Osher E; Shenkerman G; Tordjman K; Stern N
    Eur J Endocrinol; 2009 May; 160(5):839-46. PubMed ID: 19174534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen therapy in hypogonadotrophic hypogonadism: time course of erotosexual functions.
    Eyal A; Ish-Shalom S; Hoch Z; Hochberg Z
    Arch Androl; 1988; 20(2):163-9. PubMed ID: 3134862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering prolactin level in a hyperprolactinemic man: responses of luteinizing hormone, follicle-stimulating hormone, and testosterone.
    Davis JL
    Arch Intern Med; 1982 Jan; 142(1):146-8. PubMed ID: 6797361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile gonadotropin-releasing hormone in gonadotropin deficient and normal men: suppression of follicle-stimulating hormone responses by testosterone.
    Valk TW; Corley KP; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1981 Jul; 53(1):184-91. PubMed ID: 6787065
    [No Abstract]   [Full Text] [Related]  

  • 8. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
    Smith R; Donald RA; Espiner EA; Stronach SG; Edwards IA
    J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost.
    Taylor F; Levine L
    J Sex Med; 2010 Jan; 7(1 Pt 1):269-76. PubMed ID: 19694928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of male hypogonadism with testosterone enanthate.
    Snyder PJ; Lawrence DA
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1335-9. PubMed ID: 6777395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogonadal men treated with oral testosterone undecanoate.
    Sarris S; Swyer GI; Lawrence DM
    Acta Eur Fertil; 1977 Dec; 8(4):297-9. PubMed ID: 610314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men.
    Schürmeyer T; Wickings EJ; Freischem CW; Nieschlag E
    Acta Endocrinol (Copenh); 1983 Mar; 102(3):456-62. PubMed ID: 6402875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
    J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men.
    Sokol RZ; Palacios A; Campfield LA; Saul C; Swerdloff RS
    Fertil Steril; 1982 Mar; 37(3):425-30. PubMed ID: 6800853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parlodel treatment of uremic hypogonadism in men.
    Ermolenko VM; Kukhtevich AV; Dedov II; Bunatian AF; Melnichenko GA; Gitel EP
    Nephron; 1986; 42(1):19-22. PubMed ID: 3079888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.
    Wang C; Swerdloff R; Kipnes M; Matsumoto AM; Dobs AS; Cunningham G; Katznelson L; Weber TJ; Friedman TC; Snyder P; Levine HL
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3821-9. PubMed ID: 15292312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of prolactin and TSH response to TRH in hypotonadotropic hypogonadism.
    Yamaji T; Shimamoto K; Kosaka K; Isurugi K
    J Clin Endocrinol Metab; 1977 Aug; 45(2):319-23. PubMed ID: 407241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
    Tan KC; Shiu SW; Pang RW; Kung AW
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine.
    Donnelly P; White C
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):197-201. PubMed ID: 10671947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone undecanoate: a new orally active androgen.
    Hirschhäuser C; Hopkinson CR; Sturm G; Coert A
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):179-87. PubMed ID: 1098350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.